In the Boardroom
Refine Search
Biotechnology
British biotech firm Summit Pharmaceuticals has made several key appointments in its research and development unit. 23 May 2017
Biotechnology
Actelion has detailed changes to its management team that will come into effect once the Swiss biotech firm becomes part of Johnson & Johnson. 16 May 2017
Biotechnology
American biotech firm Alnylam Pharmaceuticals has made several new appointments to its senior management team. 10 May 2017
Biotechnology
Cambridge, UK-based monoclonal antibody specialist Kymab Group today announced the appointment of Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino will manage the clinical development of the group's expanding therapeutic antibody portfolio. 9 May 2017
Biotechnology
US biotech Seattle Genetics has agreed to terminate its license agreement with Immunomedics for cancer drug candidate sacituzumab govitecan (IMMU-132) and settle the related litigation. 8 May 2017
Biotechnology
Paris, France-based GenSight Biologics has appointed Mohamed Genead, the former head of ophthalmology/retina gene therapy at Biogen, as the company’s new chief medical officer. 4 May 2017
Biotechnology
Private company ImCheck Therapeutics has raised 20 million euros ($22 million) to fund research into antibodies involved in the immune system. 3 May 2017
Biotechnology
Privately-held oncology specialists Rgenix has announced the appointment of Roger Waltzman as chief medical officer. 28 April 2017
Biotechnology
Dr Ellen Donnelly, former head of clinical operations of the neuroscience and pain therapeutic area at Pfizer, has been appointed as chief executive officer at Modus Therapeutics. 24 April 2017
Biotechnology
US biotech firm Juno Therapeutics (Nasdaq: JUNO) has appointed Sunil Agarwal as president of research and development. 18 April 2017
Biotechnology
Privately-held UK biotech firm Destiny Pharma has appointed Neil Clark as chief executive and member of the board of directors, effective immediately. 13 April 2017
Biotechnology
David Hung, the founder and former chief executive of Medivation, an oncology-focused biopharma bought by US pharma giant Pfizer for $14 billion last year, has switched his attention to dementia in his role. 11 April 2017
Biotechnology
USA-based Marinus Pharmaceuticals, a biotech company focused on developing treatments for epilepsy and neuropsychiatric disorders, has appointed Lorianne Masuoka as chief medical officer. 11 April 2017
Biotechnology
Tim Harris has been appointed as executive vice president of R&D at Bioverativ, a new company focussed on hemophilia and other rare blood disorders. 11 April 2017
Biotechnology
French pharma major Sanofi (Euronext: SAN) has promoted Bill Sibold to the post of executive vice president Sanofi Genzyme, effective July 1, 2017. In this role, Mr Sibold will be a member of the executive committee. 5 April 2017
Biotechnology
US biotech firm Sarepta Therapeutics today announced the appointment of Catherine Stehman-Breen, as chief medical officer. 3 April 2017
Biotechnology
Respiratory diseases specialist Verona Pharma has announced the appointment of Richard Hennings to the company’s senior management team as commercial director. 31 March 2017
Biotechnology
US biotech firm Alexion Pharmaceuticals has appointed Ludwig Hantson as chief executive and member of the board of directors, effective immediately. 27 March 2017
Biotechnology
US-based Boston Biomedical is making new senior appointments in oncology, as the company’s founder Chiang J. Li steps down from his role as chief executive. 23 March 2017
Biotechnology
Biogen has appointed Anirvan Ghosh as senior vice president, research and early development (RED). 16 March 2017
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze